HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treating hyperlipidemia in African Americans.

Abstract
The purpose of this paper is to provide information concerning the treatment of hyperlipidemia in African Americans. There is a similar prevalence of hypercholesterolemia in Blacks and Whites, but Blacks have been neglected in most pharmacological studies of hyperlipidemia. Intimal atherosclerotic involvement of the aorta and coronary artery occurs in young Black and White males. Epidemiological studies suggest there is a higher mortality rate due to coronary disease in Blacks vs Whites in the United States. Thirty-four percent of Blacks require a fasting lipid profile and 9% of Black adults aged 20 years or older would require lipid-lowering therapy. However, fewer Blacks (26%) than Whites (47%) are aware of their hypercholesterolemia. Studies with lovastatin and pravastatin show efficacy in the treatment of hypercholesterolemia. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) is designed to determine all-cause mortality for subjects receiving pravastatin vs a control group receiving "usual care." Randomized, blinded, prospective trials are needed to assess the impact of hyperlipidemia as a risk factor, and the impact of its reduction in African Americans.
AuthorsL M Prisant, C Thurmond, V J Robinson
JournalEthnicity & disease (Ethn Dis) Vol. 10 Issue 3 Pg. 334-42 ( 2000) ISSN: 1049-510X [Print] United States
PMID11110349 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticholesteremic Agents
Topics
  • Adolescent
  • Adult
  • Black or African American
  • Aged
  • Anticholesteremic Agents (therapeutic use)
  • Awareness
  • Cardiovascular Diseases (etiology, mortality)
  • Female
  • Health Services Research
  • Humans
  • Hyperlipidemias (complications, drug therapy, ethnology)
  • Male
  • Middle Aged
  • Practice Guidelines as Topic
  • Prevalence
  • United States (epidemiology)
  • White People

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: